and the GLP-1 drugs, semaglutide and tirzepatide
Cost, patient preference, and side effects still matter, but they are all secondary to what the insurance will actually pay for. Zepbound is for adults with obesity or overweight who also have weight-related health conditions such as type 2 diabetes, cardiovascular disease, or high blood pressure
A familiar story for observers of the diet industry The solution that both Calibrate and Noom suggest for customers who stop using weight-loss drugs might sound simple, and familiar: diet, exercise, sleep, emotional health
PubMed CrossRef Page VJ, Ely EW, Gates S, et al
Otros beneficios Por ello, la gran revolucin de los nuevos frmacos est en los beneficios aadidos que promueven al modificar el tejido adiposo